WEC
AGN

Winslow Evans & Crocker’s Allergan plc AGN Stock Holding History

Winslow Evans & Crocker’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,266
Closed -$226K – 1200
2020
Q1 		$226K Buy
1,266
+220
+21% +$41.4K 0.07% 224
2019
Q4 		$202K Hold
1,046
– – 0.05% 288
2019
Q3 		$178K Hold
1,046
– – 0.05% 299
2019
Q2 		$178K Sell
1,046
-124
-11% -$17.2K 0.05% 302
2019
Q1 		$172K Sell
1,170
-436
-27% -$63.2K 0.05% 300
2018
Q4 		$218K Buy
1,606
+50
+3% +$8.2K 0.07% 253
2018
Q3 		$298K Buy
1,556
+230
+17% +$42.3K 0.09% 216
2018
Q2 		$222K Sell
1,326
-148
-10% -$23.8K 0.07% 238
2018
Q1 		$248K Sell
1,474
-194
-12% -$32.5K 0.08% 224
2017
Q4 		$273K Sell
1,668
-210
-11% -$37.7K 0.09% 215
2017
Q3 		$384K Sell
1,878
-3,110
-62% -$723K 0.13% 171
2017
Q2 		$1.21M Sell
4,988
-14,646
-75% -$3.44M 0.33% 74
2017
Q1 		$4.69M Sell
19,634
-3,234
-14% -$753K 1.47% 7
2016
Q4 		$4.8M Sell
22,868
-2,916
-11% -$604K 1.48% 9
2016
Q3 		$5.94M Sell
25,784
-188
-0.7% -$45.9K 1.7% 7
2016
Q2 		$6M Sell
25,972
-167
-0.6% -$38.5K 1.79% 6
2016
Q1 		$7.01M Sell
26,139
-263
-1% -$75.3K 2.11% 6
2015
Q4 		$8.25M Sell
26,402
-180
-0.7% -$53.6K 2.36% 2
2015
Q3 		$7.22M Buy
26,582
+20
+0.1% +$6.14K 2.27% 2
2015
Q2 		$8.06M Buy
26,562
+716
+3% +$214K 2.28% 2
2015
Q1 		$7.69M Buy
25,846
+1,802
+7% +$514K 2.18% 3
2014
Q4 		$6.19M Buy
24,044
+206
+0.9% +$51.5K 1.76% 4
2014
Q3 		$5.75M Buy
23,838
+2,654
+13% +$594K 1.65% 6
2014
Q2 		$4.73M Sell
21,184
-2,460
-10% -$509K 1.56% 7
2014
Q1 		$4.87M Sell
23,644
-3,747
-14% -$742K 1.68% 7
2013
Q4 		$4.6M Buy
+27,391
New +$4.28M 1.57% 5

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Winslow Evans & Crocker's AGN Position: Q2 2020 in Review

Winslow Evans & Crocker sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,266 shares — an estimated $226K sold.

Winslow Evans & Crocker first reported a position in AGN in Q4 2013 and held it in 26 quarters. The position peaked at $8.25M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Winslow Evans & Crocker reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Winslow Evans & Crocker sold 1,266 Allergan plc shares in Q2 2020, an estimated $226K.
  • Winslow Evans & Crocker first reported a position in Allergan plc in Q4 2013 and held it in 26 quarters.
  • Winslow Evans & Crocker's Allergan plc position peaked at $8.25M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Winslow Evans & Crocker's 13F filing for Q2 2020, filed 23 Jul 2020.